• About TSH
    • Vision
    • Pipeline
    • Collaboration
    • Corporate Video
    • Organization
    • History
    • News
  • Products
    • Prescription medication
      • Cardiovascular
      • Central Nervous
      • Gastrointestinal
      • Others
    • Patient Care
      • Overall
      • AlphaLiquid® Detect
      • AlphaLiquid®
      • AlphaLiquid®
      • AlphaSolid®
      • Lung Cancer Panel
      • UNITED™
      • Prosigna®
    • Report Query
  • Investors
    • Institutional Investor Conference
    • Financials
      • Monthly Revenues
      • Financial Reports
      • Annual Reports
    • Shareholder Serivces
      • Dividends
      • Shareholders' Meeting
      • List of Major Shareholders
    • Corporate Governance
      • Board of Directors
      • Audit Committee
      • Remuneration Committee
      • Sustainable Development Committee
      • Corporate Governance Implementation Status
      • Major Internal Policies
      • Internal Audit
  • Careers
    • Learnings and Development
    • Join TSH
  • Sustainable Development
    • Sustainability
    • Social Participation
    • Stakeholder
  • Report Query
  • Search
  • 繁
  • EN

  1. Home
  2. Investors
  3. Corporate Governance
  4. Major Internal Policies

Menu

  • About TSH
    • Vision
    • Pipeline
    • Collaboration
    • Corporate Video
    • Organization
    • History
    • News
  • Products
    • Prescription medication
      • Cardiovascular
      • Central Nervous
      • Gastrointestinal
      • Others
    • Patient Care
      • Overall
      • MPap®
      • AlphaLiquid® Detect
      • AlphaLiquid®
      • AlphaLiquid® HRR
      • AlphaSolid®
      • AlphaSolid® HRR
      • Lung Cancer Panel
      • UNITED™
      • Prosigna®
    • Report Query
  • Investors
    • Institutional Investor Conference
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Financials
      • Monthly Revenues
      • Financial Reports
      • Annual Reports
    • Shareholder Serivces
      • Dividends
      • Shareholders Meeting
      • List of Major Shareholders
    • Corporate Governance
      • Board of Directors
      • Audit Committee
      • Remuneration Committee
      • Sustainable Development Committee
      • Corporate Governance Implementation Status
      • Major Internal Policies
      • Internal Audit
  • Careers
    • Learnings and Development
    • Join TSH
  • Sustainable Development
    • Sustainability
    • Social Participation
      • 2024
        • 2024H1
        • 2024H2
      • 2023
      • 2022
      • 2021
        • Social Participation
        • Drawing Competition
      • 2020
      • 2019
      • 2018
    • Stakeholder
  • Report Query

Major Internal Policies

1
Articles of Incorporation
2
Rules of Procedure for Shareholders' Meeting
3
Rules of Procedure for Board Meeting
4
Self-Evaluation of the Board of Directors
5
Audit Committee Charter
6
Remuneration Committee Charter
7
Sustainable Development Committee Charter
8
Procedures for Acquisition or Disposal of Assets
9
Procedures for Lending Funds to Other Parties
10
Procedures for Endorsement and Guarantee
11
Corporate Governance Code of Practice
12
Sustainable Development Best Practice Principles
13
Ethical Corporate Management Best Practice Principles
14
Procedures for Ethical Management and Guidelines for Conduct
15
Codes of Ethical Conduct
16
Operating Procedures for Handling Internal Material Information and Preventing Insider Trading
17
Risk Management Policy and Procedure
18
Whistleblowing System
19
Rules Governing Financial and Business Matters Between the Company and its Affiliated Enterprises

團體服
高雄室內設計|商業設計
內褲
襪子
男內褲
軸承
  • About TSH
  • Products
  • Investors
  • Careers
  • Sustainable Development
  • Report Query
  • Contact Us
  • TEL: +886-2-2655-8525
  • FAX: +886-2-2655-8526
  • Address:3F-1, No.3-1, Park Street, Nangang District, Taipei City, Taiwan (R.O.C)
  • Copyright © 2023 TSH Biopharm All Rights Reserved.
  • Follow us -